Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Ungania

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Diagnostics (Basel, Switzerland)|December 30, 2025
Balloon-Occluded Hepatic Radioembolization with Yttrium-90 (b-TARE) in Selected Patients with Unresectable Heterogeneous Hepatocellular Carcinoma (HCC): A Safe and Effective Approach to Improve the Dose RateLeonardo Teodoli, Nicolò Ubaldi, Claudio Trobiani, et al.
Journal of Personalized Medicine|May 25, 2024
The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot StudyClaudio Trobiani, Nicolò Ubaldi, Leonardo Teodoli, et al.
Frontiers in Oncology|January 24, 2018
Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?Marco D'Andrea, Silvia Strolin, Sara Ungania, et al.
Biology|August 27, 2021
Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular CarcinomaGiulio Eugenio Vallati, Claudio Trobiani, Leonardo Teodoli, et al.
Journal of Medical Physics|August 14, 2023
Multiple Brain Metastases Radiosurgery with CyberKnife Device: Dosimetric Comparison between Fixed/Iris and Multileaf Collimator PlansAnna Ianiro, Erminia Infusino, Marco D'Andrea, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 6, 2020
Absorbed dose measurements from a <sup>90</sup>Y radionuclide liquid solution using LiF:Mg,Cu,P thermoluminescent dosimetersMarco D'Arienzo, Maria Pimpinella, Vanessa De Coste, et al.
Tumori|April 6, 2021
Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patientsGiuseppe Sanguineti, Raul Pellini, Antonello Vidiri, et al.
Cancer Medicine|January 18, 2020
Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process-A systematic reviewAntonino Guerrisi, Emiliano Loi, Sara Ungania, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2021
The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with <sup>223</sup>Ra: first in human studyRosa Sciuto, Sandra Rea, Sara Ungania, et al.
Cells|December 23, 2022
Artificial Intelligence and Advanced Melanoma: Treatment Management ImplicationsAntonino Guerrisi, Italia Falcone, Fabio Valenti, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Diagnostics (Basel, Switzerland)|December 30, 2025
Balloon-Occluded Hepatic Radioembolization with Yttrium-90 (b-TARE) in Selected Patients with Unresectable Heterogeneous Hepatocellular Carcinoma (HCC): A Safe and Effective Approach to Improve the Dose RateLeonardo Teodoli, Nicolò Ubaldi, Claudio Trobiani, et al.
Journal of Personalized Medicine|May 25, 2024
The Deterioration of Sarcopenia Post-Transarterial Radioembolization with Holmium-166 Serves as a Predictor for Disease Progression at 3 Months in Patients with Advanced Hepatocellular Carcinoma: A Pilot StudyClaudio Trobiani, Nicolò Ubaldi, Leonardo Teodoli, et al.
Frontiers in Oncology|January 24, 2018
Radiobiological Optimization in Lung Stereotactic Body Radiation Therapy: Are We Ready to Apply Radiobiological Models?Marco D'Andrea, Silvia Strolin, Sara Ungania, et al.
Biology|August 27, 2021
Sarcopenia Worsening One Month after Transarterial Radioembolization Predicts Progressive Disease in Patients with Advanced Hepatocellular CarcinomaGiulio Eugenio Vallati, Claudio Trobiani, Leonardo Teodoli, et al.
Journal of Medical Physics|August 14, 2023
Multiple Brain Metastases Radiosurgery with CyberKnife Device: Dosimetric Comparison between Fixed/Iris and Multileaf Collimator PlansAnna Ianiro, Erminia Infusino, Marco D'Andrea, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|January 6, 2020
Absorbed dose measurements from a <sup>90</sup>Y radionuclide liquid solution using LiF:Mg,Cu,P thermoluminescent dosimetersMarco D'Arienzo, Maria Pimpinella, Vanessa De Coste, et al.
Tumori|April 6, 2021
Stereotactic body radiotherapy for T1 glottic cancer: dosimetric data in 27 consecutive patientsGiuseppe Sanguineti, Raul Pellini, Antonello Vidiri, et al.
Cancer Medicine|January 18, 2020
Novel cancer therapies for advanced cutaneous melanoma: The added value of radiomics in the decision making process-A systematic reviewAntonino Guerrisi, Emiliano Loi, Sara Ungania, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 7, 2021
The role of dosimetry and biological effects in metastatic castration-resistant prostate cancer (mCRPC) patients treated with <sup>223</sup>Ra: first in human studyRosa Sciuto, Sandra Rea, Sara Ungania, et al.
Cells|December 23, 2022
Artificial Intelligence and Advanced Melanoma: Treatment Management ImplicationsAntonino Guerrisi, Italia Falcone, Fabio Valenti, et al.
Pageof 2